Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 1691.19 | 226 / 226 | 100% | 162.61 | 406 / 406 |
esophagus | 100% | 1134.17 | 1444 / 1445 | 100% | 75.83 | 183 / 183 |
brain | 100% | 1413.39 | 2632 / 2642 | 100% | 96.06 | 705 / 705 |
prostate | 100% | 1067.81 | 245 / 245 | 99% | 120.26 | 499 / 502 |
uterus | 100% | 1185.74 | 170 / 170 | 99% | 101.33 | 456 / 459 |
stomach | 100% | 1072.11 | 359 / 359 | 99% | 141.40 | 284 / 286 |
intestine | 100% | 1530.11 | 966 / 966 | 99% | 146.76 | 523 / 527 |
skin | 100% | 1079.55 | 1806 / 1809 | 99% | 107.65 | 466 / 472 |
thymus | 100% | 933.42 | 652 / 653 | 99% | 61.51 | 597 / 605 |
kidney | 100% | 3463.01 | 89 / 89 | 98% | 120.92 | 887 / 901 |
bladder | 100% | 946.76 | 21 / 21 | 98% | 105.62 | 495 / 504 |
ovary | 98% | 946.67 | 177 / 180 | 100% | 150.20 | 429 / 430 |
pancreas | 100% | 1291.61 | 328 / 328 | 98% | 84.62 | 174 / 178 |
lung | 98% | 818.62 | 569 / 578 | 98% | 80.41 | 1131 / 1155 |
adrenal gland | 100% | 2391.51 | 258 / 258 | 95% | 61.64 | 218 / 230 |
breast | 100% | 923.06 | 459 / 459 | 94% | 66.91 | 1046 / 1118 |
eye | 0% | 0 | 0 / 0 | 100% | 168.20 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 192.32 | 29 / 29 |
spleen | 100% | 1470.68 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 75.68 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 118.63 | 1 / 1 |
adipose | 99% | 885.29 | 1196 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 875.09 | 794 / 803 | 0% | 0 | 0 / 0 |
heart | 94% | 705.70 | 813 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 515.45 | 1242 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 64% | 716.67 | 597 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006195 | Biological process | purine nucleotide catabolic process |
GO_0043174 | Biological process | nucleoside salvage |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0030855 | Biological process | epithelial cell differentiation |
GO_0009159 | Biological process | deoxyribonucleoside monophosphate catabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0070694 | Molecular function | deoxyribonucleoside 5'-monophosphate N-glycosidase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DNPH1 |
Protein name | 5-hydroxymethyl-dUMP N-hydrolase (EC 3.2.2.-) (2'-deoxynucleoside 5'-phosphate N-hydrolase 1) (c-Myc-responsive protein RCL) 5-hydroxymethyl-dUMP N-hydrolase (2'-deoxynucleoside 5'-phosphate N-hydrolase 1) |
Synonyms | RCL C6orf108 |
Description | FUNCTION: Part of a nucleotide salvage pathway that eliminates epigenetically modified 5-hydroxymethyl-dCMP (hmdCMP) in a two-step process entailing deamination to cytotoxic 5-hydroxymethyl-dUMP (hmdUMP), followed by its hydrolysis into 5-hydroxymethyluracil (hmU) and 2-deoxy-D-ribose 5-phosphate (deoxyribosephosphate) . Catalyzes the second step in that pathway, the hydrolysis of the N-glycosidic bond in hmdUMP, degrading this cytotoxic nucleotide to avoid its genomic integration . . |
Accessions | H0Y8X4 O43598 ENST00000509253.5 ENST00000393987.2 [O43598-2] ENST00000230431.11 [O43598-1] |